Glaucoma Today

Glaucoma Today Glaucoma Today delivers information on recent research, surgical techniques, clinical strategies, therapeutics, and technology. A BMC Vision publication.

GT offers readers balanced coverage of the topics that matter most! Glaucoma Today is mailed bimonthly (six times a year) to 11,121 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. The publication profiles leaders in the field of glaucoma, and contributing authors present challenging cases as a source of education for readers. Glaucoma Tod

ay delivers balanced coverage of the topics that matter most. Twitter: https://twitter.com/GlaucomaToday
Instagram: https://www.instagram.com/glaucomatoday/

From the early days of their medical training, physicians learn the principle to do no harm and are encouraged to avoid ...
02/06/2025

From the early days of their medical training, physicians learn the principle to do no harm and are encouraged to avoid conducting invasive procedures unless they are medically necessary.

The default approach is, in the absence of an acute emergency, to rely on medical management first before turning to surgery.

Since the advent of selective laser trabeculoplasty (SLT), however, the traditional glaucoma treatment paradigm has been shifting. Continue reading this article from Catherine Johnson, MD, MPH, and Barbara Wirostko, MD, FARVO here: https://bit.ly/4gvJbax

02/04/2025

N. Troy Gurney, MD, and Richard K. Lee, MD, PhD, recap their article, “Pearls for Effective Laser Cyclophotocoagulation of the Glaucomatous Eye,” which was featured in a recent issue of Glaucoma Today. They make the case that transscleral cyclophotocoagulation should be considered earlier in the glaucoma treatment algorithm and review the proper technique and indications to maximize effectiveness and minimize complications: https://bit.ly/4jCVrZH

This retrospective cohort study assessed whether future rapid visual field (VF) worsening could be predicted with the us...
01/31/2025

This retrospective cohort study assessed whether future rapid visual field (VF) worsening could be predicted with the use of deep learning models (DLMs). A total of 4,536 eyes from 2,962 patients monitored for glaucoma or suspected glaucoma were evaluated.

Eight DLMs were trained on baseline clinical data, including age, s*x, BCVA, and IOP; OCT data; and VFs, including reliability data and mean deviation.

Read more on this issue from Julius T. Oatts, MD, and Ying Han, MD, PhD here: https://bit.ly/40SOHiS

01/29/2025

In this video, Dr. Richman demonstrates a sideways sweeping motion to break scarring in the angle. He also addresses synechiae at the pupil and opens Schlemm canal. https://bit.ly/3CogRc5

The first International Glaucoma Symposium will be held by Heidelberg Engineering in conjunction with Mainz University o...
01/22/2025

The first International Glaucoma Symposium will be held by Heidelberg Engineering in conjunction with Mainz University on February 1, 2025:

The first International Glaucoma Symposium will be held by Heidelberg Engineering in conjunction with Mainz University on February 1, 2025. Bringin

01/15/2025

In this video, Eric Rosenberg, DO, MScEng, showcases how technology can augment surgical procedures such as MIGS in real-world applications. He demonstrates how visualization with Ngenuity (Alcon) provides a clear view of the angle structures during iStent Infinite (Glaukos) implantation. Continue watching here: https://bit.ly/4gViPjc

Bausch + Lomb announced two seperate deals to acquire early- and mid-stage therapeutic assets.First, B+L, through an aff...
01/13/2025

Bausch + Lomb announced two seperate deals to acquire early- and mid-stage therapeutic assets.

First, B+L, through an affiliate, acquired Whitecap Biosciences LLC, which is currently developing two therapies for potential use in glaucoma and geographic atrophy (GA). Financial tems of the deal were not disclosed. Continue reading here: https://bit.ly/3WjzvZv

01/07/2025

Start the year strong with the latest issue of GT: "Drug Delivery – New Takes on a Longtime Challenge in Care." Explore it now at glaucomatoday.com.

👁️ January is National Glaucoma Awareness Month!Glaucoma is a leading cause of vision loss, affecting millions worldwide...
01/03/2025

👁️ January is National Glaucoma Awareness Month!

Glaucoma is a leading cause of vision loss, affecting millions worldwide—but early detection can make all the difference. Join us in spreading awareness, sharing knowledge, and prioritizing eye health.

💡 Stay informed. Get screened. Protect your sight.

01/02/2025

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Lorraine M. Provencher, MD, and Brian Shafer, MD, to review a real case from his practice.

They discuss details of the case, including patient risk factors and possible treatment goals, and weigh their options for managing the case in the most effective manner while still leaving options on the table for future treatment.

Later, the panelists find out how their colleagues would manage the case, based on results of a social media poll of GT’s audience. Listen in here: https://bit.ly/3P9854n

As part of January’s National Glaucoma Awareness Month, the non-profit Prevent Blindness is offering free educational re...
01/02/2025

As part of January’s National Glaucoma Awareness Month, the non-profit Prevent Blindness is offering free educational resources to patients, care partners, and professionals:

As part of January’s National Glaucoma Awareness Month, the non-profit Prevent Blindness is offering free educational resources to pat

University of Connecticut scientists have published a report in the September issue of Experimental Neurology, showing i...
12/30/2024

University of Connecticut scientists have published a report in the September issue of Experimental Neurology, showing injured optic nerves can regrow towards the brain if treated properly: https://bit.ly/3DCAEVo

12/26/2024

What is the impact of benzalkonium chloride on the long-term health of the eye? According to Jason Bacharach, MD, there are implications beyond just the impact on the ocular surface: https://bit.ly/3BAXn3E

In this article commemorating 75 years of innovation at  , learn more about the company’s investment in R&D of different...
12/23/2024

In this article commemorating 75 years of innovation at , learn more about the company’s investment in R&D of different sustained-release platforms and medications, and surgical treatments that may help reduce patients’ reliance on medications. https://bit.ly/3ZGb754

12/17/2024

I. Paul Singh, MD, shares this teaching video to help other surgeons understand how to address the nasal trabecular meshwork using the OMNI Surgical System (Sight Sciences).

Financial Disclosure: Consultant (Sight Sciences): https://bit.ly/49JTvtR

Learn where the MINIject supraciliary MIGS device fits into Dr. I. Paul Singh’s glaucoma treatment paradigm. He discusse...
12/10/2024

Learn where the MINIject supraciliary MIGS device fits into Dr. I. Paul Singh’s glaucoma treatment paradigm. He discusses the device’s safety and efficacy and shares his clinical experience. Watch here: https://bit.ly/4imp1lk

MINIject is an investigational device in the US and not for sale.

ViaLase announced a research partnership with the John A. Moran Eye Center at the University of Utah (Moran Eye Center),...
12/10/2024

ViaLase announced a research partnership with the John A. Moran Eye Center at the University of Utah (Moran Eye Center), home to the Alan S. Crandall Center for Glaucoma Innovation (Crandall Center). The collaboration will explore aqueous outflow dynamics of ViaLase’s ViaLase laser procedure, utilizing Moran’s iPerfusion technology: https://bit.ly/4fbHGNO

12/04/2024

Austin Bohner, MD, and Craig Chaya, MD, present their preferred surgical bleb revision technique they call "excise and mobilize." The technique involves removing necrotic tissue and advancing healthy conjunctiva.

They say this approach preserves the flap filtration architecture and it is imperative to use a sharp instrument to facilitate the dissection plane. If inadequate conjunctiva remains for closure, shunt removal and patch grafting may be necessary. Continue watching here: https://bit.ly/3D9wF2d

Address

Wayne, PA

Alerts

Be the first to know and let us send you an email when Glaucoma Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Glaucoma Today:

Videos

Share

Category